$heff's $tation of $tocks & $olid DD

[Investor100]

CRIS:Curis and Debiopharm Announce Initiation of Phase Ib Expansion Study of HSP90 Inhibitor Debio 0932

LEXINGTON, Mass., and LAUSANNE, Switzerland, Feb. 16, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS - News), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, and Debiopharm Group (Debiopharm), a group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced that Debiopharm has begun treating patients in a Phase Ib clinical trial of Heat Shock Protein 90 (HSP90) inhibitor Debio 0932. Debiopharm recently successfully completed a Phase Ia dose escalation study with Debio 0932 and has indicated that it expects to initiate a combination Phase I/II study in non-small cell lung cancer patients in the second quarter of 2012.

http://finance.yahoo.com/news/Curis-Debiopharm-Announce-pz-881485314.html?x=0

Investor 100